January 20, 2026, Boston, MA: Catalyst Health Ventures (CHV), a venture capital firm focused on advancing transformative medical technologies, today announced the promotion of David Mackey to Partner. Mackey has served as the firm’s Chief Financial Officer for four years and is the first person to be promoted to partner since Josh Phillips and Darshana Zaveri founded the firm.
Since joining CHV in 2021, Mackey has played a pivotal role in strengthening and scaling the firm’s operations. His leadership has supported CHV’s continued growth and its mission to partner with entrepreneurs developing innovative solutions to address unmet clinical needs.
“Dave has played a meaningful role in the evolution of Catalyst Health Ventures,” said Darshana Zaveri, Co-Founder and Managing Partner, CHV. “Over the past four years, he has helped transform the firm by building a strong financial, operational and legal foundation, while serving as a trusted partner to our team and portfolio companies. We are proud to welcome him as a Partner.”
Joshua S. Phillips, Co-Founder and Managing Partner, CHV, added, “This promotion reflects both Dave’s exceptional contributions and the values we hold as a firm. His deep experience across finance, operations, and transactions, combined with his understanding of building successful healthcare companies, has made him an invaluable part of our team. Expanding our partnership in this way is an important milestone for our firm.”
Prior to joining CHV, Mackey held senior leadership roles at multiple Catalyst portfolio companies. Earlier in his career, he was Chief Financial Officer at AgNovos Healthcare, where he led finance, administration, and business development initiatives.
Before entering the MedTech industry, Mackey spent six years as an investment banker at J.P. Morgan in New York, advising companies and investment firms on mergers and acquisitions, divestitures, IPOs, follow-on offerings, and debt financings. He began his career as a corporate attorney at Gibson, Dunn & Crutcher, focusing on M&A and securities offerings.
“I’m honored to become a Partner at Catalyst Health Ventures,” said David Mackey, Partner, CHV. “CHV has a long-standing reputation for supporting entrepreneurs tackling some of the most meaningful challenges in MedTech, and it’s been a privilege to work alongside Darshana, Josh, and the broader team. I’m excited to continue working closely with our portfolio companies and partners as we support technologies that can truly improve patient outcomes.”
About Catalyst Health Ventures
Catalyst Health Ventures invests in transformative MedTech companies that are addressing global unmet healthcare needs and have the potential to become the new standard of care. Our thesis is exclusively focused on innovative early stage therapeutic devices, diagnostics and digital health solutions that significantly improve outcomes for patients, providers and payers.